摘要
目的汉化关于癌症生命末期照护决策的家属决策自我效能量表(family decision-making self-efficacy scale,FDMSE),并对量表进行信效度检验,以评价该量表在晚期癌症患者家属参与生命末期照护决策领域的适用性。方法通过翻译、整合、回译、专家委员会审核及预调查,形成中文版FDMSE量表。使用该量表对广州市某三级甲等肿瘤医院的145例晚期癌症患者的家属进行调查,评价量表的信、效度。结果中文版FDMSE量表的条目水平内容效度指数、量表水平的内容效度均为1.0;探索性因子分析共提取3个公因子,包括治疗决策、舒适促进决策、面对死亡决策;量表的Cronbach’sα系数为0.859,折半信度为0.897。结论中文版FDMSE量表具有良好的信效度,可以用于评估晚期癌症患者家属参与患者生命末期照护决策的自信心。
Objective To develop the Chinese Version of Family Decision-Making Self-Efficacy Scale(FDMSE)and to evaluate its reliability and validity.Then to evaluate the applicability of the scale in the field of family decision-making in end-of-life care of patients with advanced cancer.Methods The Chinese version of the FDMSE was formed by translation,synthesis,back translation,expert committee review and pretest.A survey was conducted among 145 family members of advanced cancer patients in a tertiary A cancer hospital in Guangzhou to evaluate its reliability and validity.Results The item-level CVI and scale-level CVI of the Chinese version of FDMSE were both 1.0.The exploratory factor analysis showed that there were 3 factors including treatment decision-making,comfort promotion decision-making,and facing death decision-making.The Cronbach’sαcoefficients of the scale was 0.859,and the split-half reliability of the scale was 0.897.Conclusions The Chinese version of the FDMSE has good reliability and validity.It can be used to assess family members’self-confidence in participating in end-of-life care decisions for patients with advanced cancer.
作者
胡扬帆
彭雪兰
赵娟娟
HU Yangfan;PENG Xuelan;ZHAO Juanjuan(School of Nursing,Sun Yat-sen University,Guangzhou 510080,Guangdong Province,China;Department of Intensive Care Unit,Sun Yat-sen University Cancer Center,Guangzhou 510060,Guangdong Province,China)
出处
《解放军护理杂志》
CSCD
北大核心
2022年第4期42-44,48,共4页
Nursing Journal of Chinese People's Liberation Army
基金
国家自然科学基金项目(72004243)
中山大学高校青年教师团队项目(2021qntd33)。
关键词
癌症
生命末期照护
家属决策自我效能
信度
效度
cancer
end-of-life care
family decision-making self-efficacy
reliability
validity
